121 related articles for article (PubMed ID: 20705533)
1. The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.
Hentschel S; Heinz J; Schmid-Höpfner S; Obi N; Vettorazzi E; Chang-Claude J; Flesch-Janys D
Cancer Epidemiol; 2010 Oct; 34(5):639-43. PubMed ID: 20705533
[TBL] [Abstract][Full Text] [Related]
2. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.
Chikman B; Lavy R; Davidson T; Wassermann I; Sandbank J; Siegelmann-Danieli N; Halevy A
Isr Med Assoc J; 2010 Nov; 12(11):697-700. PubMed ID: 21243872
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
5. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
7. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
Saltzstein SL
Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
[No Abstract] [Full Text] [Related]
8. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
10. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.
Bouchardy C; Usel M; Verkooijen HM; Fioretta G; Benhamou S; Neyroud-Caspar I; Schaffar R; Vlastos G; Wespi Y; Schäfer P; Rapiti E
Breast Cancer Res Treat; 2010 Apr; 120(2):519-23. PubMed ID: 19633953
[TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
12. The rise and fall in menopausal hormone therapy and breast cancer incidence.
Pelucchi C; Levi F; La Vecchia C
Breast; 2010 Jun; 19(3):198-201. PubMed ID: 20172726
[TBL] [Abstract][Full Text] [Related]
13. Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women.
Almquist M; Anagnostaki L; Bondeson L; Bondeson AG; Borgquist S; Landberg G; Malina J; Malm J; Manjer J
Eur J Cancer Prev; 2009 Sep; 18(5):354-60. PubMed ID: 19593149
[TBL] [Abstract][Full Text] [Related]
14. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
Vankrunkelsven P; Kellen E; Lousbergh D; Cloes E; Op de Beeck L; Faes C; Bruckers L; Mertens R; Coebergh JW; Van Leeuwen FE; Buntinx F
Breast Cancer Res Treat; 2009 Nov; 118(2):425-32. PubMed ID: 19238536
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.
Ravdin PM
Breast Dis; 2008-2009; 30():3-8. PubMed ID: 19850989
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
[TBL] [Abstract][Full Text] [Related]
17. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
18. Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible.
Banks E; Canfell K
Breast Cancer Res; 2010; 12(1):103. PubMed ID: 20236464
[TBL] [Abstract][Full Text] [Related]
19. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004.
Ahn SH; Yoo KY;
Breast Cancer Res Treat; 2006 Sep; 99(2):209-14. PubMed ID: 16862450
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
